e-learning
resources
Virtual 2021
07.09.2021
Biomarkers to phenotype COPD: prediction of exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is FEV1/FEV6 ratio a reliable tool in COPD diagnosis ?
S. Chakroun (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
Source:
Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Session:
Biomarkers to phenotype COPD: prediction of exacerbations
Session type:
E-poster
Number:
3440
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Chakroun (Tunis, Tunisia), A. Chaker (Tunis, Tunisia), S. Mokaddem (Tunis, Tunisia), K. Kchaou (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia). Is FEV1/FEV6 ratio a reliable tool in COPD diagnosis ?. 3440
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Is spirometry screening useful for detecting undiagnosed COPD?
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011
Spirometric diagnosis of COPD: is postbronchodilator test reliable?
Source: Eur Respir J 2006; 28: Suppl. 50, 39s
Year: 2006
Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Use FEV6 and FEV1/FEV6 as alternative indicators in the diagnosis of bronchial obstruction in primary care
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Spirometry screening in the community: is this an effective way of diagnosing early COPD?
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005
Are FENO indices useful diagnostic tools in suspected asthma? Experience of a routine lung function laboratory
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker?
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020
Is it possible to improve the prediction ability of the BODE index?
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Serial FEV1 measurements: an improved diagnostic tool for occupational asthma?
Source: International Congress 2017 – Asthma: clinical and epidemiologic characterisation
Year: 2017
Is it useful CD4+CD103+/CD4+ ratio for the diagnosis of lung sarcoidosis?
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
A network-based approach to defining phenotypes in COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Capnovolumetry as a cooperation free method in the diagnosis and monitoring of COPD
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Can the FEV
1
/FEV
6
ratio be measured accurately in general practice?
Source: Annual Congress 2007 - Assessing the airways: innovation, applications and pitfalls
Year: 2007
FEV1/FEV6 and FEV6: sensitivity and specificity in detecting obstructive and restrictive disease of older patients
Source: Annual Congress 2008 - Quality spirometry: the only spirometry!
Year: 2008
Capnographic measurement as a screening method for respiratory obstructive diseases
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Predictive value of spirometry trend and FeNO for difficult to treat asthma in children
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010
Can non-invasive measurements of respiratory phase angle offer a surrogate of disease severity in COPD? 2- Tidal breathing data
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013
Case-finding for COPD: Developing strategies to identify patients at risk populations
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Accuracy of questionnaire with peak flow for diagnosis of airway obstruction and differentiating between asthma and COPD
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept